Late-Stage Vaccine Trials From Pfizer, Moderna May Have Encouraged Investors
(Tuesday Market Open) As earnings season shifts into a higher gear during this busy week, investors not only have quarterly corporate performance on their mind but also the congressional debate about another round of stimulus and a Fed meeting where market participants are likely hoping to hear that central bankers are willing to do more to help the beleaguered economy.
